Tzu-yi Liao

Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.

Journal: International journal of biological macromolecules

Published: October 27, 2025

To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.

To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.

Journal: NPJ vaccines

Published: May 28, 2025

Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy.

Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy.

Journal: International journal of biological macromolecules

Published: February 17, 2025

Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer.

Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer.

Journal: International journal of biological macromolecules

Published: September 05, 2024

Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety.

Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety.

Journal: International journal of biological macromolecules

Published: August 29, 2024

Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo.

Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo.

Journal: Biomaterials research

Published: August 07, 2024

Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery.

Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery.

Journal: International journal of nanomedicine

Published: May 29, 2024

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.

Journal: Scientific reports

Published: March 12, 2021

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.

Journal: Journal of nanobiotechnology

Published: September 24, 2020

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer.

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer.

Journal: Journal of nanobiotechnology

Published: May 11, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026